Akzo Nobel (OTCMKTS:AKZOY – Get Free Report) saw a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 11,200 shares, a decline of 80.2% from the October 31st total of 56,700 shares. Based on an average daily trading volume, of 230,600 shares, the days-to-cover ratio is presently 0.0 days.
Akzo Nobel Stock Performance
Shares of OTCMKTS:AKZOY opened at $19.43 on Thursday. The firm’s 50 day simple moving average is $21.71 and its 200 day simple moving average is $21.45. Akzo Nobel has a fifty-two week low of $19.08 and a fifty-two week high of $27.99. The company has a market capitalization of $9.96 billion, a price-to-earnings ratio of 19.24, a P/E/G ratio of 0.68 and a beta of 1.30. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.21 and a quick ratio of 0.89.
Akzo Nobel (OTCMKTS:AKZOY – Get Free Report) last issued its earnings results on Wednesday, October 23rd. The basic materials company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.38 by $0.04. The firm had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.01 billion. Akzo Nobel had a net margin of 4.47% and a return on equity of 12.16%. As a group, sell-side analysts forecast that Akzo Nobel will post 1.45 earnings per share for the current year.
Akzo Nobel Cuts Dividend
About Akzo Nobel
Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. The company operates through two segments: Decorative Paints and Performance Coatings. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings.
Read More
- Five stocks we like better than Akzo Nobel
- How to Use the MarketBeat Stock Screener
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best Stocks Under $10.00
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 5 discounted opportunities for dividend growth investors
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Akzo Nobel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akzo Nobel and related companies with MarketBeat.com's FREE daily email newsletter.